>I read recently HCV advocates are anxious for IDIX and VRTX to test their drugs in coinfected patients, I wasn't aware that IDIX has now added a coinfected cohort.<
They haven’t yet but they plan to.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”